Press release
Biomaterials Market Responds to Aging Population's Orthopedic Implant Demand: Set to Exceed US$ 654.4 Billion by 2032
The global Biomaterials Market is anticipated to grow at a moderate CAGR of 15.4% between 2022 and 2032, reaching a market worth of US$ 156.2 billion by 2022. By the end of 2032, the market for biomaterials is projected to be worth roughly US$ 654.4 billion.The demand for implantable devices is expected to rise as the incidence of cardiovascular disorders, orthopedic replacements, arthritis, and sports injuries increase. Chronic health issues are also brought on by poor habits, inactivity, and an ageing population. This is changing the biomaterials market outlook.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐๐ญ๐ก ๐๐จ ๐๐ฎ๐๐๐๐ฌ๐ฌ ๐๐ง๐ ๐๐ซ๐จ๐ฌ๐ฉ๐๐ซ๐ข๐ญ๐ฒ ๐๐ข๐ญ๐ก ๐๐ฎ๐ซ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ - ๐๐๐ญ ๐๐จ๐ฎ๐ซ ๐๐จ๐ฉ๐ฒ ๐๐จ๐ฐ! https://www.futuremarketinsights.com/reports/sample/rep-gb-15168
As per the biomaterials market analysis, over the past few years, biomaterials have become more in demand and used in a variety of medical applications. Numerous government agencies and academic institutions have offered their assistance by way of investments, finances, and grants to advance study into the creation of innovative biomaterials.
The biomaterials market study indicates that the devices made of biomaterials must go through a rigorous clinical and regulatory process to assure their effectiveness and quality. Because of this, the biomaterials market participants are reluctant to invest in this market. These are the elements that are anticipated to limit the biomaterials market expansion over the prediction period.
The demand for biomaterial-based implants is anticipated to increase due to the increased prevalence of musculoskeletal and chronic skeletal medical disorders, which will fuel biomaterials market expansion. The growing elderly population, who are at a higher risk of osteoarthritis, osteoporosis, and other musculoskeletal problems, is another factor driving up demand for orthopedic implants.
During the anticipated period, the biomaterials market in emerging nations is anticipated to expand significantly. This is mostly due to the growing patient population, rising implanted device usage, more CVD awareness, rising disposable income, improved healthcare infrastructure, and the existence of less strict regulatory rules (in comparison to developed countries) in these countries.
๐๐๐ฒ ๐๐๐ค๐๐๐ฐ๐๐ฒ๐ฌ ๐๐ซ๐จ๐ฆ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐ฎ๐๐ฒ:
โข Due to the broad range of product applications, the polymer product category led the biomaterials market in terms of revenue in 2021 with a share of 28.2 percent and is predicted to maintain its dominance throughout the forecast period.
โข With a revenue share of 23.0 percent in 2021, the orthopaedic application segment dominated the biomaterials market in terms of revenue.
โข Due to the rise in aesthetic surgeries and the use of biomaterials during these operations, the plastic surgery application segment is anticipated to expand significantly over the next several years increasing the sales.
โข Because of several public and private organisations' initiatives, North America dominated the biomaterials market and had the highest revenue share of 38.2 percent in 2021.
โข During the anticipated period, Europe is anticipated to hold the second-largest biomaterials market share. Market expansion in the region is largely due to key companies launching more cutting-edge items on the market.
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The main methods used by the prominent companies to maintain their biomaterials market dominance are the expansion of product portfolios through various new product developments and inorganic growth through acquisition, mergers, and partnerships. Additionally, a focus on strategically growing their global footprint through a network of global distribution channels is expected to provide them a strong foothold in the biomaterials industry.
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐ก๐ ๐๐ซ๐ญ ๐๐ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ ๐๐๐๐ข๐ฌ๐ข๐จ๐ง-๐๐๐ค๐ข๐ง๐ ๐๐ข๐ ๐๐ฎ๐ซ ๐๐๐ญ๐ก๐จ๐๐จ๐ฅ๐จ๐ ๐ฒ! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15168
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ ๐ข๐ง ๐๐ฅ๐จ๐๐๐ฅ ๐๐จ๐ฅ๐ฒ๐๐๐ซ๐๐จ๐ง๐๐ญ๐ ๐๐๐ซ๐ค๐๐ญ:
In order to meet the unique requirements and demand for care in ambulatory surgery centres (ASCs) and office-based laboratories, Medtronic and GE Healthcare established a partnership in April 2022. (OBLs). As a result of this new agreement, customers will have access to a wide range of products, financial solutions, and excellent support.
A biomanufacturing platform is being developed by US-based startup Transfoam. The startup's bioprocess turns plastic waste into totally biodegradable polyhydroxybutyrate using engineered microorganisms (PHB). After disposal, PHB only leaves a small amount of carbon dioxide and water behind. It also has characteristics with conventional single-use plastics. As a result, producers are better equipped to replace single-use plastics and lessen environmental damage, which helps with the shift to a circular economy.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
โข Medtronic plc
โข Evonik Industries AG
โข Carpenter Technology Corporation
โข Berkeley Advanced Biomaterials
โข Invibio Ltd.
โข Zimmer Biomet Holdings, Inc.
โข BASF SE
โข Covalon Technologies Ltd.
โข Stryker
โข Johnson & Johnson
โข Dentsply Sirona
โข CoorsTek Inc.
โข Corbion
๐๐ข๐จ๐ฆ๐๐ญ๐๐ซ๐ข๐๐ฅ๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
๐๐ฒ ๐๐ซ๐จ๐๐ฎ๐๐ญ:
โข Metallic
โข Natural
โข Ceramics
โข Polymers
๐๐ฒ ๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง:
โข Cardiovascular
o Sensors
o Stents
o Guidewires
o Implantable Cardiac Defibrillators
o Pacemakers
o Vascular Grafts
o Others
โข Ophthalmology
o Synthetic Corneas
o Intraocular Lens
o Contact Lens
o Ocular Tissue Replacement
o Others
โข Dental
o Tissue Regeneration Materials
o Dental Implants
o Bone Grafts & Substitutes
o Dental Membranes
o Others
โข Orthopedic
o Joint Replacement Biomaterials
o Orthobiologics
o Bioresorbable Tissue Fixation Products
o Viscosupplementation
o Spine Biomaterials
o Others
โข Wound Healing
o Fracture Healing Device
o Adhesion Barrier
o Skin Substitutes
o Internal Tissue Sealant
o Surgical Hemostats
o Others
Neurological Biomarkers Market: https://www.futuremarketinsights.com/reports/neurological-biomarkers-market
Gynaecological Examination Chairs Market: https://www.futuremarketinsights.com/reports/gynaecological-examination-chairs-market
Muscle Stimulation Devices Market: https://www.futuremarketinsights.com/reports/muscle-stimulation-devices-market
๐๐๐จ๐ฎ๐ญ ๐ ๐ฎ๐ญ๐ฎ๐ซ๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ (๐ ๐๐)
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
๐ ๐จ๐ซ ๐๐๐ฅ๐๐ฌ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ข๐๐ฌ: sales@futuremarketinsights.com
๐๐๐๐ฌ๐ข๐ญ๐: https://www.futuremarketinsights.com
๐๐ซ๐จ๐ฐ๐ฌ๐ ๐ ๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.futuremarketinsights.com/reports/biomaterials-market
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biomaterials Market Responds to Aging Population's Orthopedic Implant Demand: Set to Exceed US$ 654.4 Billion by 2032 here
News-ID: 3180944 • Views: โฆ
More Releases from Future Market Insights Inc

Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project โฆ
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and isโฆ

NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 โฆ
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, drivenโฆ

Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus โฆ
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation.
Click Here for More Information:-โฆ

Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I โฆ
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market
Dermatologyโฆ
More Releases for Biomaterials
Biomaterials: Core Growth Enabler in the Rising Incidence Of Cardiovascular Dise โฆ
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Biomaterials Industry Market Size Be by 2025?
The biomaterials industry has seen a swift expansion in its market size in recent years. The market is projected to climb from $134.31 billion in 2024 to $153.55 billion in 2025, advancing at a compound annual growth rate (CAGR) of 14.3%. The historic growthโฆ
Uncovering Biomaterials Market Dynamics
The biomaterials market size is expected to be valued at USD 144.9 Billion in 2024 and reach USD 285.3 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Biomaterials are substances engineered to interact with biological systems for medical purposes, either therapeutic or diagnostic. They play a crucial role in medicine by restoring function and facilitating healing for people after injury or disease. Biomaterials are naturalโฆ
Natural Biomaterials Market Ongoing Trends and Recent Developments | Key Players โฆ
This detailed market study covers natural biomaterials market growth potentials which can assist the stake holders to understand key trends and prospects in natural biomaterials market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify scope and opportunities. Theโฆ
Biomaterials Market 2019 Growth Opportunities: DSM, Zimmer Biomet, DePuy Synthes โฆ
The Biomaterials market is anticipated to grow in the forecast, owing to the factors such as rising geriatric population, increasing prevalence of cardiovascular, neurological and orthopedic disorders, heavy funding by government organizations to launch novel products, rising awareness regarding the advantages of biomaterial products and advancements in technology.
The Biomaterials Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraintsโฆ
Natural Biomaterials Market Opportunity Analysis, 2018โ2026: BASF SE, Biomet, โฆ
Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials isโฆ
Natural Biomaterials Market Industry Analysis 2026: BASF SE, Biomet, Inc., Invib โฆ
Biomaterials have gained tremendous attention in tissue engineering and regenerative medicine applications attributing to their ability to enhance functional tissue regeneration. Biomaterial can be categories into natural biomaterials and synthetic biomaterials. Natural biomaterials offer various advantages over synthetic biomaterials such as they already have binding sites for cells and adhesion molecules so the biocompatibility is not a major issue. On account of advantages offered, the demand for natural biomaterials isโฆ